Evidence map›Paper›PMID 32824881›Full record

ArticleInternational journal of molecular sciences2020

The Molecular Basis and Biologic Significance of the β-Dystroglycan-Emerin Interaction.

Wendy Lilián Gómez-Monsivais, Feliciano Monterrubio-Ledezma, Jazmin Huerta-Cantillo, Ricardo Mondragon-Gonzalez, Alma Alamillo-Iniesta, Ian García-Aguirre, Paulina Margarita Azuara-Medina, Raúl Arguello-García, Jhon Erick Rivera-Monroy, James M Holaska and 8 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Natural History of Dilated Cardiomyopathy Due toJournal of clinical medicine · 2024
    Article
  5. Review
  6. The Role of Emerin in Cancer Progression and Metastasis.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 5 countries.

Wendy Lilián Gómez-MonsivaisDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.
Feliciano Monterrubio-LedezmaDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.
Jazmin Huerta-CantilloCell Biology Department, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.
Ricardo Mondragon-GonzalezDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.
Alma Alamillo-IniestaDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.
Ian García-AguirreDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.
Paulina Margarita Azuara-MedinaDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.
Raúl Arguello-GarcíaDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.
Jhon Erick Rivera-MonroyDepartment of Molecular Biology, Faculty of Medicine, GZMB, Georg-August University, 37073 Göttingen, Germany.ORCID 0000-0002-6911-9988
James M HolaskaDepartment of Biomedical Sciences, Cooper Medical School of Rowan University, 401 S Broadway, Camden, NJ 08028, USA.ORCID 0000-0003-0273-9995
Jesús Mauricio Ernesto Hernández-MéndezDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.ORCID 0000-0001-7153-4964
Efraín GarridoDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.
Jonathan Javier MagañaLaboratory of Genomic Medicine, Department of Genetics, National Rehabilitation Institute-Luis Guillermo Ibarra Ibarra (INR-LGII), 14389 Mexico City, Mexico.ORCID 0000-0003-4399-4618
Steve J WinderDepartment of Biomedical Science, University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
Andrea BrancaccioSchool of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.ORCID 0000-0003-4690-8826
Ivette Martínez-VieyraLaboratory of Hematobiology, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, 07320 Ciudad de México, Mexico.
Fernando Navarro-GarciaCell Biology Department, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.
Bulmaro CisnerosDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), 07360 Mexico City, Mexico.
Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional · MXCooper Medical School of Rowan University · USInstituto Nacional de Rehabilitación · MXInstituto Politécnico Nacional · MXUniversity of Bristol · GBUniversity of Göttingen · DEUniversity of Sheffield · GB

Funding

Emerin regulation of myogenic differentiation: implications for muscle diseaseR15AR069935 · NIAMS · UNIVERSITY OF THE SCIENCES PHILADELPHIA · PI JAMES Michael HOLASKA · 2016 to 2026
$2.0M
Bilateral Agreement CNR (Italy)/CINVESTAV (Mexico) CNR2018/4NIAMS NIH HHS R15 AR069935SEP-CINVESTAV Reference 242
6 · The paper itself

Abstract

β-dystroglycan (β-DG) assembles with lamins A/C and B1 and emerin at the nuclear envelope (NE) to maintain proper nuclear architecture and function. To provide insight into the nuclear function of β-DG, we characterized the interaction between β-DG and emerin at the molecular level. Emerin is a major NE protein that regulates multiple nuclear processes and whose deficiency results in Emery-Dreifuss muscular dystrophy (EDMD). Using truncated variants of β-DG and emerin, via a series of in vitro and in vivo binding experiments and a tailored computational analysis, we determined that the β-DG-emerin interaction is mediated at least in part by their respective transmembrane domains (TM). Using surface plasmon resonance assays we showed that emerin binds to β-DG with high affinity (KD in the nanomolar range). Remarkably, the analysis of cells in which DG was knocked out demonstrated that loss of β-DG resulted in a decreased emerin stability and impairment of emerin-mediated processes. β-DG and emerin are reciprocally required for their optimal targeting within the NE, as shown by immunofluorescence, western blotting and immunoprecipitation assays using emerin variants with mutations in the TM domain and B-lymphocytes of a patient with EDMD. In summary, we demonstrated that β-DG plays a role as an emerin interacting partner modulating its stability and function.

Indexed as

Active Transport, Cell NucleusAnimalsBinding SitesB-LymphocytesCell LineCells, CulturedDystroglycansHeLa CellsHumansMembrane ProteinsMiceMuscular Dystrophy, Emery-DreifussMutationNuclear EnvelopeNuclear ProteinsProtein BindingDystroglycansemerinMembrane ProteinsNuclear ProteinsemerinEmery-Dreifuss muscular dystrophynuclear envelopeproteasomesurface plasmon resonance assayβ-dystroglycan

Identifiers

PMID32824881
PMCPMC7504044
OpenAlexW3053872012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.